ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,152 | -22.8% | 42,866 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $1,493 | +10.5% | 41,867 | -21.3% | 0.00% | 0.0% |
| Q1 2023 | $1,351 | -90.5% | 53,200 | -84.9% | 0.00% | -90.0% |
| Q4 2022 | $14,286 | -99.9% | 352,222 | +0.9% | 0.02% | +17.6% |
| Q3 2022 | $11,535,000 | -6.1% | 349,022 | -0.0% | 0.02% | +6.2% |
| Q2 2022 | $12,290,000 | -23.3% | 349,041 | +0.2% | 0.02% | -5.9% |
| Q1 2022 | $16,024,000 | -30.8% | 348,422 | -0.2% | 0.02% | -26.1% |
| Q4 2021 | $23,158,000 | +6.6% | 349,295 | +0.4% | 0.02% | 0.0% |
| Q3 2021 | $21,719,000 | -30.3% | 347,892 | -7.6% | 0.02% | -28.1% |
| Q2 2021 | $31,167,000 | +28.1% | 376,325 | +2.6% | 0.03% | +18.5% |
| Q1 2021 | $24,324,000 | -15.8% | 366,822 | -2.5% | 0.03% | -15.6% |
| Q4 2020 | $28,881,000 | +82.9% | 376,392 | +2.6% | 0.03% | +68.4% |
| Q3 2020 | $15,791,000 | -0.9% | 366,722 | -0.7% | 0.02% | -5.0% |
| Q2 2020 | $15,942,000 | +53.7% | 369,122 | +2.4% | 0.02% | +25.0% |
| Q1 2020 | $10,375,000 | -54.6% | 360,622 | 0.0% | 0.02% | -40.7% |
| Q4 2019 | $22,874,000 | +117.1% | 360,622 | -3.5% | 0.03% | +107.7% |
| Q3 2019 | $10,534,000 | +1.6% | 373,822 | -4.5% | 0.01% | 0.0% |
| Q2 2019 | $10,372,000 | +52.1% | 391,392 | +5.3% | 0.01% | +44.4% |
| Q1 2019 | $6,820,000 | +51.9% | 371,657 | +2.8% | 0.01% | +28.6% |
| Q4 2018 | $4,491,000 | +141.1% | 361,622 | +272.0% | 0.01% | +250.0% |
| Q3 2018 | $1,863,000 | +41.7% | 97,200 | +0.5% | 0.00% | 0.0% |
| Q2 2018 | $1,315,000 | +1202.0% | 96,700 | +77.8% | 0.00% | – |
| Q1 2017 | $101,000 | +20.2% | 54,401 | +0.0% | 0.00% | – |
| Q4 2016 | $84,000 | -79.0% | 54,400 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $400,000 | +38.4% | 54,400 | 0.0% | 0.00% | – |
| Q2 2016 | $289,000 | – | 54,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |